What happened
Original notice title
Meta Labs Pharmaceuticals, LLC MARCS-CMS 725130, May 15, 2026
From the archived source record
Based on inspectional findings and review of the product labels collected during the inspection, as well as review of your website at www.metalabsinc.com, we have identified significant violations of the Federal Food, Drug, and Cosmetic Act (the Act) and applicable regulations. Unapproved New Drugs FDA reviewed your website at the Internet address www.metalabsinc.com in April of 2026 and has determined that you take orders there for the products Yacon Root Extract, Nattokinase Max, Viral Immune Booster, Arthritis Bursitis Rheumatism, and Respiratory Response. In addition, FOS has important beneficial physiological effects, such as reducing the risk of colon and rectal cancer, reducing cholesterol, triglycerides, and phospholipids in the blood, promotes a better immune response that increases resistance to infections an allergies, improves calcium and magnesium absorption, magnesium uptake leads to a reduced risk of colorectal cancer. . . . Misbranded Drugs A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, Diabetic Advantage, Yacon Root Extract, Nattokinase Max, Viral Immune Booster, and Respiratory Response fail to bear adequate directions for their intended use and, therefore, the products are misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]. The introduction or delivery for introduction into interstate commerce of these misbranded drugs violates section 301(a) of the Act [21 U.S.C. 331(a)]. Adulterated Dietary Supplements The inspection of your facility from December 8 through December 18, 2025, identified serious violations of the FDA’s regulations for Current Good Manufacturing Practice (CGMP) in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements, under Title 21, Code of Federal Regulations (CFR), Part 111 (21 CFR Part 111).
What the official notice says to do
Check the original notice for the instructions that apply to the named product, company, and affected lots.
Read the official notice →Status and source details
- Status recorded in the archive
- No closeout listed in FDA table
- Source checked
- Jul 16, 2026
- Record revision
- ade17805cb3b
This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.
Sources, dates, and coverage →